Logo image of CTAC.AS

CTAC NV (CTAC.AS) Stock Fundamental Analysis

Europe - Euronext Amsterdam - AMS:CTAC - NL0000345577 - Common Stock

3.05 EUR
-0.03 (-0.97%)
Last: 1/7/2026, 4:11:13 PM
Fundamental Rating

5

CTAC gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 73 industry peers in the IT Services industry. There are concerns on the financial health of CTAC while its profitability can be described as average. CTAC scores decently on growth, while it is valued quite cheap. This could make an interesting combination. CTAC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

CTAC had positive earnings in the past year.
CTAC had a positive operating cash flow in the past year.
CTAC had positive earnings in each of the past 5 years.
In the past 5 years CTAC always reported a positive cash flow from operatings.
CTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFCTAC.AS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M

1.2 Ratios

Looking at the Return On Assets, with a value of 5.74%, CTAC is in the better half of the industry, outperforming 67.12% of the companies in the same industry.
The Return On Equity of CTAC (13.36%) is better than 64.38% of its industry peers.
CTAC has a Return On Invested Capital of 7.06%. This is comparable to the rest of the industry: CTAC outperforms 43.84% of its industry peers.
CTAC had an Average Return On Invested Capital over the past 3 years of 7.76%. This is significantly below the industry average of 26.63%.
Industry RankSector Rank
ROA 5.74%
ROE 13.36%
ROIC 7.06%
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
CTAC.AS Yearly ROA, ROE, ROICCTAC.AS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

CTAC has a Profit Margin (3.28%) which is comparable to the rest of the industry.
In the last couple of years the Profit Margin of CTAC has grown nicely.
CTAC has a Operating Margin (4.54%) which is comparable to the rest of the industry.
CTAC's Operating Margin has improved in the last couple of years.
The Gross Margin of CTAC (54.86%) is worse than 60.27% of its industry peers.
CTAC's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.54%
PM (TTM) 3.28%
GM 54.86%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
CTAC.AS Yearly Profit, Operating, Gross MarginsCTAC.AS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), CTAC is creating some value.
CTAC has about the same amout of shares outstanding than it did 1 year ago.
CTAC has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CTAC has an improved debt to assets ratio.
CTAC.AS Yearly Shares OutstandingCTAC.AS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Yearly Total Debt VS Total AssetsCTAC.AS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M

2.2 Solvency

CTAC has an Altman-Z score of 2.97. This is not the best score and indicates that CTAC is in the grey zone with still only limited risk for bankruptcy at the moment.
CTAC's Altman-Z score of 2.97 is in line compared to the rest of the industry. CTAC outperforms 58.90% of its industry peers.
A Debt/Equity ratio of 0.37 indicates that CTAC is not too dependend on debt financing.
CTAC has a Debt to Equity ratio of 0.37. This is comparable to the rest of the industry: CTAC outperforms 58.90% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Altman-Z 2.97
ROIC/WACC1.09
WACC6.5%
CTAC.AS Yearly LT Debt VS Equity VS FCFCTAC.AS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

2.3 Liquidity

A Current Ratio of 1.00 indicates that CTAC should not have too much problems paying its short term obligations.
CTAC has a Current ratio of 1.00. This is in the lower half of the industry: CTAC underperforms 63.01% of its industry peers.
A Quick Ratio of 1.00 indicates that CTAC should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.00, CTAC perfoms like the industry average, outperforming 41.10% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1
Quick Ratio 1
CTAC.AS Yearly Current Assets VS Current LiabilitesCTAC.AS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M

6

3. Growth

3.1 Past

CTAC shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 351.71%, which is quite impressive.
The Earnings Per Share has been growing by 24.20% on average over the past years. This is a very strong growth
Looking at the last year, CTAC shows a small growth in Revenue. The Revenue has grown by 0.81% in the last year.
The Revenue has been growing by 8.74% on average over the past years. This is quite good.
EPS 1Y (TTM)351.71%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%15.97%
Revenue 1Y (TTM)0.81%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%1.44%

3.2 Future

The Earnings Per Share is expected to grow by 21.55% on average over the next years. This is a very strong growth
Based on estimates for the next years, CTAC will show a small growth in Revenue. The Revenue will grow by 7.12% on average per year.
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y5.84%
Revenue Next 5Y7.12%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CTAC.AS Yearly Revenue VS EstimatesCTAC.AS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 50M 100M 150M
CTAC.AS Yearly EPS VS EstimatesCTAC.AS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

7

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.52 indicates a reasonable valuation of CTAC.
94.52% of the companies in the same industry are more expensive than CTAC, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of CTAC to the average of the S&P500 Index (27.17), we can say CTAC is valued rather cheaply.
The Price/Forward Earnings ratio is 7.12, which indicates a rather cheap valuation of CTAC.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CTAC indicates a rather cheap valuation: CTAC is cheaper than 94.52% of the companies listed in the same industry.
CTAC is valuated cheaply when we compare the Price/Forward Earnings ratio to 23.79, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 10.52
Fwd PE 7.12
CTAC.AS Price Earnings VS Forward Price EarningsCTAC.AS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CTAC's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. CTAC is cheaper than 87.67% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 4.46
CTAC.AS Per share dataCTAC.AS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8

4.3 Compensation for Growth

CTAC's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as CTAC's earnings are expected to grow with 21.55% in the coming years.
PEG (NY)0.22
PEG (5Y)0.43
EPS Next 2Y30.93%
EPS Next 3Y21.55%

7

5. Dividend

5.1 Amount

CTAC has a Yearly Dividend Yield of 3.59%. Purely for dividend investing, there may be better candidates out there.
Compared to an average industry Dividend Yield of 2.29, CTAC pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.94, CTAC pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.59%

5.2 History

The dividend of CTAC is nicely growing with an annual growth rate of 17.13%!
Dividend Growth(5Y)17.13%
Div Incr Years0
Div Non Decr Years1
CTAC.AS Yearly Dividends per shareCTAC.AS Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 0.02 0.04 0.06 0.08 0.1

5.3 Sustainability

CTAC pays out 37.91% of its income as dividend. This is a sustainable payout ratio.
The dividend of CTAC is growing, but earnings are growing more, so the dividend growth is sustainable.
DP37.91%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
CTAC.AS Yearly Income VS Free CF VS DividendCTAC.AS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M
CTAC.AS Dividend Payout.CTAC.AS Dividend Payout, showing the Payout Ratio.CTAC.AS Dividend Payout.PayoutRetained Earnings

CTAC NV

AMS:CTAC (1/7/2026, 4:11:13 PM)

3.05

-0.03 (-0.97%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners6.76%
Inst Owner ChangeN/A
Ins Owners22.27%
Ins Owner ChangeN/A
Market Cap43.16M
Revenue(TTM)125.22M
Net Income(TTM)4.10M
Analysts85
Price Target2.97 (-2.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.59%
Yearly Dividend0.11
Dividend Growth(5Y)17.13%
DP37.91%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-22.4%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 10.52
Fwd PE 7.12
P/S 0.34
P/FCF N/A
P/OCF 18.39
P/B 1.41
P/tB 10.11
EV/EBITDA 4.46
EPS(TTM)0.29
EY9.51%
EPS(NY)0.43
Fwd EY14.05%
FCF(TTM)-0.1
FCFYN/A
OCF(TTM)0.17
OCFY5.44%
SpS8.85
BVpS2.17
TBVpS0.3
PEG (NY)0.22
PEG (5Y)0.43
Graham Number3.76
Profitability
Industry RankSector Rank
ROA 5.74%
ROE 13.36%
ROCE 15.2%
ROIC 7.06%
ROICexc 7.47%
ROICexgc 21.3%
OM 4.54%
PM (TTM) 3.28%
GM 54.86%
FCFM N/A
ROA(3y)4.34%
ROA(5y)4.75%
ROE(3y)10.63%
ROE(5y)12.49%
ROIC(3y)7.76%
ROIC(5y)7.73%
ROICexc(3y)9.86%
ROICexc(5y)10.11%
ROICexgc(3y)93.05%
ROICexgc(5y)116.82%
ROCE(3y)14.76%
ROCE(5y)14.73%
ROICexgc growth 3Y-10.84%
ROICexgc growth 5Y39.25%
ROICexc growth 3Y-2.56%
ROICexc growth 5Y15.11%
OM growth 3Y-9.71%
OM growth 5Y12.14%
PM growth 3Y-9.09%
PM growth 5Y15.3%
GM growth 3Y-5.24%
GM growth 5Y-3.9%
F-Score5
Asset Turnover1.75
Health
Industry RankSector Rank
Debt/Equity 0.37
Debt/FCF N/A
Debt/EBITDA 1.02
Cap/Depr 69.4%
Cap/Sales 2.97%
Interest Coverage 14.65
Cash Conversion 21.25%
Profit Quality N/A
Current Ratio 1
Quick Ratio 1
Altman-Z 2.97
F-Score5
WACC6.5%
ROIC/WACC1.09
Cap/Depr(3y)40.73%
Cap/Depr(5y)30.86%
Cap/Sales(3y)1.72%
Cap/Sales(5y)1.4%
Profit Quality(3y)401.58%
Profit Quality(5y)373.89%
High Growth Momentum
Growth
EPS 1Y (TTM)351.71%
EPS 3Y-5.51%
EPS 5Y24.2%
EPS Q2Q%15.97%
EPS Next Y46.94%
EPS Next 2Y30.93%
EPS Next 3Y21.55%
EPS Next 5YN/A
Revenue 1Y (TTM)0.81%
Revenue growth 3Y5.32%
Revenue growth 5Y8.74%
Sales Q2Q%1.44%
Revenue Next Year7.26%
Revenue Next 2Y6.26%
Revenue Next 3Y5.84%
Revenue Next 5Y7.12%
EBIT growth 1Y24.33%
EBIT growth 3Y-4.9%
EBIT growth 5Y21.94%
EBIT Next Year66.67%
EBIT Next 3Y25.99%
EBIT Next 5YN/A
FCF growth 1Y-114.47%
FCF growth 3Y-7.01%
FCF growth 5Y0.39%
OCF growth 1Y-79.51%
OCF growth 3Y2.52%
OCF growth 5Y4.91%

CTAC NV / CTAC.AS FAQ

What is the fundamental rating for CTAC stock?

ChartMill assigns a fundamental rating of 5 / 10 to CTAC.AS.


Can you provide the valuation status for CTAC NV?

ChartMill assigns a valuation rating of 7 / 10 to CTAC NV (CTAC.AS). This can be considered as Undervalued.


Can you provide the profitability details for CTAC NV?

CTAC NV (CTAC.AS) has a profitability rating of 5 / 10.


What is the financial health of CTAC NV (CTAC.AS) stock?

The financial health rating of CTAC NV (CTAC.AS) is 3 / 10.


Can you provide the dividend sustainability for CTAC stock?

The dividend rating of CTAC NV (CTAC.AS) is 7 / 10 and the dividend payout ratio is 37.91%.